MOXD1
Basic information
Region (hg38): 6:132296055-132401475
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MOXD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 39 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 0 | 0 |
Variants in MOXD1
This is a list of pathogenic ClinVar variants found in the MOXD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-132297175-G-A | not specified | Uncertain significance (Aug 23, 2021) | ||
6-132297302-C-A | not specified | Uncertain significance (Apr 27, 2023) | ||
6-132297788-G-A | not specified | Uncertain significance (Sep 29, 2023) | ||
6-132297912-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
6-132315642-G-T | not specified | Uncertain significance (Aug 08, 2023) | ||
6-132315666-T-A | not specified | Uncertain significance (May 17, 2023) | ||
6-132315710-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
6-132315722-C-A | not specified | Uncertain significance (Aug 08, 2023) | ||
6-132315726-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
6-132315738-G-T | not specified | Uncertain significance (Jan 27, 2022) | ||
6-132315746-A-T | not specified | Uncertain significance (Jun 05, 2023) | ||
6-132315767-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
6-132320657-T-C | not specified | Uncertain significance (Jun 02, 2023) | ||
6-132320664-G-A | not specified | Uncertain significance (Jul 11, 2023) | ||
6-132322725-T-C | not specified | Uncertain significance (Nov 07, 2022) | ||
6-132322734-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
6-132322753-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
6-132322776-C-T | not specified | Uncertain significance (Nov 06, 2023) | ||
6-132322786-G-T | not specified | Uncertain significance (Jan 30, 2024) | ||
6-132322838-A-T | not specified | Uncertain significance (Dec 17, 2023) | ||
6-132323938-A-G | not specified | Uncertain significance (Nov 29, 2023) | ||
6-132323951-T-A | not specified | Uncertain significance (May 13, 2022) | ||
6-132323980-A-G | not specified | Uncertain significance (Jun 02, 2023) | ||
6-132323987-G-A | not specified | Uncertain significance (Jun 10, 2022) | ||
6-132324035-C-G | not specified | Uncertain significance (Jan 30, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MOXD1 | protein_coding | protein_coding | ENST00000367963 | 12 | 105491 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.55e-22 | 0.000359 | 125601 | 1 | 146 | 125748 | 0.000585 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.542 | 350 | 323 | 1.08 | 0.0000155 | 4014 |
Missense in Polyphen | 152 | 137.07 | 1.1089 | 1645 | ||
Synonymous | -0.131 | 125 | 123 | 1.01 | 0.00000629 | 1143 |
Loss of Function | -0.412 | 32 | 29.6 | 1.08 | 0.00000159 | 342 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000908 | 0.000907 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.00181 | 0.00180 |
European (Non-Finnish) | 0.000627 | 0.000624 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000360 | 0.000327 |
Other | 0.000661 | 0.000652 |
dbNSFP
Source:
- Pathway
- Tyrosine metabolism;Pyrimidine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.231
Intolerance Scores
- loftool
- 0.817
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.46
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.511
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.150
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Moxd1
- Phenotype
- growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- octopamine biosynthetic process;dopamine catabolic process;norepinephrine biosynthetic process;oxidation-reduction process
- Cellular component
- extracellular space;cytoplasm;endoplasmic reticulum membrane;integral component of membrane;secretory granule membrane
- Molecular function
- dopamine beta-monooxygenase activity;copper ion binding;protein binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen